Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

MITOTANE for Neoplasm malignant: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 10 adverse event reports in the FDA FAERS database where MITOTANE was used for Neoplasm malignant.

Most Reported Side Effects for MITOTANE

Side Effect Reports % Deaths Hosp.
Nausea 210 20.8% 6 37
Fatigue 205 20.3% 10 42
Off label use 154 15.2% 11 25
Diarrhoea 123 12.2% 3 22
Vomiting 97 9.6% 6 29
Drug ineffective 86 8.5% 10 25
Decreased appetite 77 7.6% 5 25
Adrenal insufficiency 76 7.5% 2 18
Dizziness 76 7.5% 2 12
Asthenia 70 6.9% 3 24
Malignant neoplasm progression 61 6.0% 15 14
Neutropenia 48 4.8% 4 7
Febrile neutropenia 42 4.2% 2 4
Headache 42 4.2% 1 11
Anaemia 41 4.1% 2 12

Other Indications for MITOTANE

Adrenocortical carcinoma (461) Adrenal gland cancer (250) Product used for unknown indication (88) Metastases to lung (25) Metastases to liver (23) Cushing's syndrome (22) Metastatic neoplasm (22) Adjuvant therapy (18) Chemotherapy (10) Adrenal gland cancer metastatic (9)

Other Drugs Used for Neoplasm malignant

PALBOCICLIB (1,996) CAPECITABINE (1,493) PEMBROLIZUMAB (1,135) PACLITAXEL (984) CARBOPLATIN (977) NIVOLUMAB (947) OXALIPLATIN (823) PAZOPANIB (716) CYCLOPHOSPHAMIDE (685) FLUOROURACIL (676)

Related Pages

MITOTANE Full Profile All Neoplasm malignant Drugs MITOTANE Demographics MITOTANE Timeline